急性肝脏孔水症是什么
Inês Marques1, Pedro Marcos2,3
1Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
Porto biomedical journal
|November 25, 2025
概括
急性肝脏 (AHP) 是一种罕见的遗传性疾病,导致衰弱的神经瘤发作. 早期诊断和管理对于预防慢性并发症和改善患者结果至关重要.
科学领域:
- 生物化学 生物化学
- 遗传学 遗传学 是一个
- 内部医学 内部医学
背景情况:
- 毛孔病是一种罕见的遗传疾病,源于血生物合成酶的突变.
- 这些突变导致有毒氨酸前体的积累,导致各种症状.
- 本综述侧重于急性肝脏 (AHP),这是这些疾病的一个子集.
研究的目的:
- 审查目前对急性肝脏孔水症 (AHP) 的理解.
- 突出AHP的诊断方法和治疗策略.
- 强调识别AHP和管理其慢性并发症的重要性.
主要方法:
- 通过PubMed.使用MEDLINE进行了全面的文献审查.
- 系统审查,临床试验,队列研究,病例控制研究,专家评价和指导方针是优先考虑的.
- 分析的重点是了解AHP的呈现,诊断和管理.
主要成果:
- 有四种类型的AHP存在:急性间歇性形性形症,多种形性形症,遗传性形性形症和δ-氨基烯酸脱水酶缺乏性形症.
- 典型情况下,AHP呈现为带有严重腹部疼痛,神经精神症状或皮肤病变的神经瘤发作,主要影响15-50岁的女性.
- 诊断包括生物化学测试 (ALA,PBG,氨酸) 和基因测试以确定定型;治疗包括高葡萄糖饮食,血红素,吉沃西兰和肝移植作为治疗方法.
- 慢性并发症如肝细胞癌,病和高血压需要监测.
结论:
- 由于AHP仍未得到充分的认可,因此需要在患有无法解释的腹痛,神经病变,精神症状或皮肤病变的患者中考虑.
- 需要改进的诊断技术和新的治疗选择,以有效管理AHP.
- 及时诊断和全面管理对于减轻AHP及其相关慢性健康问题的影响至关重要.
更多相关视频
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
170
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
170
Hepatic Portal System
5.1K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
5.1K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
204
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
204
Hepatic Drug Excretion: Influencing Factors
508
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
508
Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
241
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
241


